Using TNF-α-targeting siRNA (siTNF-α) cytokine to suppress the production of the pro-inflammatory TNF-α cytokine selectively is a novel approach for the treatment of RA [30,31,32]. The gene discussed is TNF; the disease is rheumatoid arthritis.